CN110693776A - Dandruff-removing and itching-relieving scalp essence and preparation method thereof - Google Patents
Dandruff-removing and itching-relieving scalp essence and preparation method thereof Download PDFInfo
- Publication number
- CN110693776A CN110693776A CN201911013093.0A CN201911013093A CN110693776A CN 110693776 A CN110693776 A CN 110693776A CN 201911013093 A CN201911013093 A CN 201911013093A CN 110693776 A CN110693776 A CN 110693776A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- xylitol
- percent
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004761 scalp Anatomy 0.000 title claims abstract description 54
- 208000001840 Dandruff Diseases 0.000 title claims abstract description 41
- 208000003251 Pruritus Diseases 0.000 title abstract description 29
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 239000000284 extract Substances 0.000 claims abstract description 78
- 239000000203 mixture Substances 0.000 claims abstract description 64
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims abstract description 37
- OQLKNTOKMBVBKV-UHFFFAOYSA-N hexamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 OQLKNTOKMBVBKV-UHFFFAOYSA-N 0.000 claims abstract description 36
- 229960001915 hexamidine Drugs 0.000 claims abstract description 36
- 239000002537 cosmetic Substances 0.000 claims abstract description 29
- 241001071795 Gentiana Species 0.000 claims abstract description 13
- 239000012676 herbal extract Substances 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 78
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 76
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 43
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 39
- 229960005323 phenoxyethanol Drugs 0.000 claims description 39
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 38
- 238000003756 stirring Methods 0.000 claims description 38
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 32
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 32
- 239000000811 xylitol Substances 0.000 claims description 32
- 229960002675 xylitol Drugs 0.000 claims description 32
- 235000010447 xylitol Nutrition 0.000 claims description 32
- 239000003814 drug Substances 0.000 claims description 26
- 229930182478 glucoside Natural products 0.000 claims description 20
- 150000008131 glucosides Chemical class 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 241001289529 Fallopia multiflora Species 0.000 claims description 16
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 16
- 235000013399 edible fruits Nutrition 0.000 claims description 16
- 239000011701 zinc Substances 0.000 claims description 16
- 229910052725 zinc Inorganic materials 0.000 claims description 16
- 241000989077 Vitex rotundifolia Species 0.000 claims description 15
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 14
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 14
- 239000003908 antipruritic agent Substances 0.000 claims description 14
- 229940041616 menthol Drugs 0.000 claims description 14
- 238000001816 cooling Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000008236 heating water Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 239000002453 shampoo Substances 0.000 claims description 6
- KZVAAIRBJJYZOW-VPENINKCSA-N (2r,3r,4s)-2-(hydroxymethyl)oxolane-3,4-diol Chemical compound OC[C@H]1OC[C@H](O)[C@H]1O KZVAAIRBJJYZOW-VPENINKCSA-N 0.000 claims description 5
- 229940083987 anhydroxylitol Drugs 0.000 claims description 5
- 230000001139 anti-pruritic effect Effects 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 2
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000007803 itching Effects 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 13
- 239000000243 solution Substances 0.000 description 26
- 238000009472 formulation Methods 0.000 description 20
- 239000003795 chemical substances by application Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 241000555676 Malassezia Species 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 4
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 229960003344 climbazole Drugs 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 229960004125 ketoconazole Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- LOEUPVXIWVJADW-UHFFFAOYSA-N 2-aminoethanol;1h-pyridin-2-one Chemical compound NCCO.O=C1C=CC=CN1 LOEUPVXIWVJADW-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241001135871 Gentiana scabra Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000001667 Vitex agnus castus Nutrition 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- 241001643642 Viticis Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000009347 chasteberry Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Abstract
The invention belongs to the field of cosmetics, and particularly relates to dandruff-removing and itching-relieving scalp essence and a preparation method thereof. The composition comprises the following components: hexamidine di (isethionate) salt and herbal extract, the herbal extract comprising gentian extract. The scalp essence prepared by the composition disclosed by the invention has good dissolubility and also has good effects of removing dandruff and relieving itching.
Description
Technical Field
The invention belongs to the field of cosmetics, and particularly relates to dandruff-removing and itching-relieving scalp essence and a preparation method thereof.
Background
With the increasing environmental pollution and fast-paced lifestyles, more and more people are troubled by the problems of scurf, itchy head and the like. Dandruff is produced because scalp is constantly metabolized, and if metabolism is abnormal, excessive scalp cells are exfoliated and become anucleate and inanimate cuticle, thereby causing dandruff problems.
The living conditions of people are improved, personal hygiene is paid more and more attention, and the frequency of hair washing is changed from once every 2-3 days to once a day. However, penetration of some raw materials and impurities thereof in shampoo formulations irritates the scalp, possibly causing allergic reactions, thereby causing scalp itching.
At present, no aqueous solution retention type functional product aiming at scurf and scalp itch exists in the market. The common anti-dandruff agents in the market are mainly: zinc pyrithione sulfate (abbreviated as ZPT), pyridone ethanolamine (abbreviated as OCT), climbazole (trade name: climbazole), ketoconazole, and the like. Wherein, the ketoconazole is used as a medicine and is prohibited from being used in cosmetics; OCT is not widely used because of high cost and easy discoloration; ganbaosu is easy to cause drug resistance and is less used. ZPT is currently the most used scalp disinfectant. Meanwhile, because ZPT, OCT, climbazole and the like are insoluble in water, the antidandruff agents are difficult to be applied to aqueous scalp essence to achieve an ideal antidandruff effect. The dandruff-removing and itching-relieving shampoo put out in the washing and caring market cannot stay on the scalp for a long time to take effect, has weak efficacy and no pertinence to the scalp, and cannot meet the requirements of people on dandruff removal and itching relieving at all.
Disclosure of Invention
The present invention aims to provide a novel composition.
It is another object of the present invention to provide a novel composition for the removal of dandruff.
It is another object of the present invention to provide a novel composition for relieving itching.
It is a further object of the present invention to provide a cosmetic composition.
It is a further object of the present invention to provide a scalp care composition.
It is a further object of the present invention to provide a scalp care composition which is stable and has good solubility.
The invention further aims to provide scalp essence with better effects of removing dandruff and relieving itching.
To solve the above technical problems, in one aspect, the present invention provides a composition comprising the following components: hexamidine di (isethionate) salt and herbal extract; the Chinese medicinal extract comprises radix Gentianae extract.
In some embodiments, the herbal extract further comprises one or both of a vitex rotundifolia fruit extract and a polygonum multiflorum root extract.
As a preferred embodiment, the composition further comprises a combination of an extract of vitex rotundifolia fruit and an extract of polygonum multiflorum root.
In some embodiments, the composition comprises the following components in parts by weight: 0.001-0.1 parts of hexamidine di (isethionic acid) salt and 0.1-5 parts of traditional Chinese medicine extract.
In some embodiments, the composition comprises the following components in parts by weight: the paint comprises the following components in parts by weight: 0.001-0.08 part of hexamidine di (isethionic acid) salt and 0.3-3 parts of traditional Chinese medicine extract.
In some embodiments, the composition comprises the following components in parts by weight: 0.001-0.05 parts of hexamidine di (isethionic acid) salt and 0.5-2 parts of traditional Chinese medicine extract.
In some embodiments, the composition further comprises p-hydroxyacetophenone and phenoxyethanol.
In some embodiments, the composition comprises the following components in parts by weight: 0.1-1 part of p-hydroxyacetophenone and 0.1-1 part of phenoxyethanol.
In some embodiments, the composition comprises the following components in parts by weight: 0.1-0.8 part of p-hydroxyacetophenone and 0.1-0.8 part of phenoxyethanol.
In some embodiments, the composition comprises the following components in parts by weight: 0.1-0.5 part of p-hydroxyacetophenone and 0.1-0.5 part of phenoxyethanol.
In some embodiments, the mass ratio of the vitex rotundifolia fruit extract, the gentian extract and the polygonum multiflorum root extract in the traditional Chinese medicine extract is (1-50): (1-50): (1-50).
In some embodiments, the mass ratio of the vitex rotundifolia fruit extract, the gentian extract and the polygonum multiflorum root extract in the traditional Chinese medicine extract is (1-20): (20-50): (10-40).
In some embodiments, the mass ratio of the vitex rotundifolia fruit extract, the gentian extract and the polygonum multiflorum root extract in the traditional Chinese medicine extract is (1-10): (30-50): (20-40).
In another aspect, the invention provides the use of said composition for regulating dandruff or for relieving itching of the scalp; or in cosmetics.
In some embodiments, the cosmetic is scalp essence or shampoo.
In another aspect, the present invention provides a cosmetic comprising the composition; the cosmetic also comprises ethanol, butanediol and water.
In some embodiments, the composition further comprises zinc PCA and xylitol-based glucoside & anhydroxylitol & xylitol.
In some embodiments, the cosmetic comprises the following components in parts by weight: 1-20 parts of ethanol, 1-5 parts of butanediol, 80-90 parts of water, 0.1-0.5 part of PCA zinc and 0.1-1 part of xylitol-based glucoside and dehydrated xylitol.
In some embodiments, the cosmetic comprises the following components in parts by weight: 5-15 parts of ethanol, 2-5 parts of butanediol, 85-90 parts of water, 0.1-0.3 part of PCA zinc and 0.2-1 part of xylitol-based glucoside and dehydrated xylitol.
In some embodiments, the cosmetic comprises the following components in parts by weight: 10-15 parts of ethanol, 3-5 parts of butanediol, 88-90 parts of water, 0.1-0.2 part of PCA zinc and 0.2-0.7 part of xylitol-based glucoside and dehydrated xylitol.
In some embodiments, the cosmetic comprises the following components in weight percent: 0.1 to 1 percent of p-hydroxyacetophenone; hexamidine di (isethionic acid) salt 0.001% -0.1%; 0.1 to 0.5 percent of phenoxyethanol; 0.1 to 5 percent of traditional Chinese medicine extract; xylitol-based glucoside & anhydroxylitoxylite & xylitol 0.1% -1%; 0.1 to 0.5 percent of PCA zinc; 1% -20% of ethanol; 1% -5% of butanediol; water to 100 percent.
In some embodiments, the cosmetic comprises the following components in weight percent: the cosmetic comprises the following components in percentage by weight: 0.1 to 0.8 percent of p-hydroxyacetophenone; hexamidine di (isethionic acid) salt 0.001% -0.08%; 0.1 to 0.8 percent of phenoxyethanol; 0.3 to 3 percent of traditional Chinese medicine extract; xylitol-based glucoside & anhydroxylitol & xylitol 0.2% -1%; 0.1 to 0.3 percent of PCA zinc; 5% -15% of ethanol; 2% -5% of butanediol; water to 100 percent.
In some embodiments, the cosmetic comprises the following components in weight percent: 0.1 to 0.5 percent of p-hydroxyacetophenone; hexamidine di (isethionate) salt 0.001% -0.05%; 0.1 to 0.5 percent of phenoxyethanol; 0.5 to 2 percent of traditional Chinese medicine extract; xylitol-based glucoside & anhydroxylitoxylite & xylitol 0.2% -0.7%; 0.1% -0.2% of PCA zinc; 10% -15% of ethanol; 3% -5% of butanediol; water to 100 percent.
In some embodiments, the cosmetic further comprises menthol and a fragrance.
In some embodiments, the menthol is present in an amount of 0.01% to 0.1% by weight.
In still another aspect, the present invention provides a method for preparing the cosmetic, comprising the steps of:
(1) premixing p-hydroxyacetophenone and butanediol at 0-30 ℃, heating to 80-85 ℃, and stirring until the p-hydroxyacetophenone and the butanediol are dissolved;
(2) premixing ethanol, menthol, essence and phenoxyethanol at 0-30 ℃, and stirring until the ethanol, the menthol, the essence and the phenoxyethanol are dissolved;
(3) heating water to 60-70 ℃ at 0-30 ℃, adding the premixed solution of p-hydroxyacetophenone and butanediol obtained in the step (1), adding hexamidine di (hydroxyethyl sulfonate) salt, and uniformly stirring until the mixture is completely dispersed;
(4) cooling the solution in the step (3) to below 45 ℃, and then adding the ethanol, menthol, essence and phenoxyethanol premixed solution in the step (2);
(5) adding the traditional Chinese medicine extract, xylitol-based glucoside, dehydrated xylitol and PCA zinc into the solution obtained in the step (4), and stirring until the traditional Chinese medicine extract, the xylitol-based glucoside, the dehydrated xylitol and the xylitol are completely dissolved;
(6) mixing, filtering, and taking out.
Compared with the prior art, one embodiment of the invention has the beneficial effects that:
1. compared with other anti-dandruff agents, the composition added with hexamidine di (isethionic acid) salt has better stability and is more soluble in water, so that the aqueous product of the invention can more easily exert anti-dandruff effect.
2. The scalp essence prepared from the composition has good effects of removing dandruff and relieving itching.
Drawings
FIG. 1 is a flow chart of the preparation of the combination of Chinese medicinal extracts of the present invention.
FIG. 2 is a flow chart of the preparation of Vitex agnus-castus fruit extract.
FIG. 3 is a flow chart of the preparation of Gentiana scabra Bunge extract.
FIG. 4 is a flow chart of the preparation of the Polygonum multiflorum root extract.
Fig. 5 is a comparison of formula 19 before and after the scalp of the subject.
Fig. 6 is a comparison of the scalp before and after the subject had formula 20.
Fig. 7 is a comparison of the scalp before and after the scalp of the subject of formula 21.
Fig. 8 is a comparison of the scalp of the subject of formula 22.
Detailed Description
The technical solutions of the present invention are further illustrated by the following specific examples, which do not represent limitations to the scope of the present invention. Insubstantial modifications and adaptations of the present invention by others of the concepts fall within the scope of the invention.
The components described in the examples of the invention are derived as follows:
ethanol, available from Anhuite food products, Inc.;
butanediol, available from KH NEOchem;
xylitol-based glucoside & anhydroxylitol & xylitol are the INCI name for Aquaxyl, purchased from the french saibec company;
p-hydroxyacetophenone, available from Xin corporation, Germany;
phenoxyethanol, available from Guangzhou Henan Fine chemical Co., Ltd;
PCA zinc was purchased from Shanghai atlas Industrial development, Inc.;
hexamidine di (isethionate) salt was purchased from lion, tokyo, inc;
menthol was purchased from yuwen limited, shanghai;
oxidized corn oil was purchased from Ashland corporation;
the decolorized gentian anti-irritant factor is purchased from Shanghai Gao Yu Biotech limited;
the natural compound polyphenol scurf-removing and itching-relieving agent is purchased from three scientific and technological development ltd of Zhou Qing city;
TEWL values refer to transdermal water loss values.
Example 1
TABLE 1
The preparation method comprises the following steps:
(1) premixing p-hydroxyacetophenone and butanediol at the temperature of 20-30 ℃, heating to 80-85 ℃, and stirring until the p-hydroxyacetophenone and the butanediol are dissolved;
(2) premixing ethanol, essence and phenoxyethanol at 20-30 ℃, and stirring until the ethanol, the essence and the phenoxyethanol are dissolved;
(3) heating water to 60-70 ℃ at 20-30 ℃, adding the pre-mixed solution of p-hydroxyacetophenone and butanediol in the step (1), uniformly stirring, adding the anti-dandruff agent, and stirring until the anti-dandruff agent is uniformly dispersed;
(4) cooling the solution in the step (3) to below 45 ℃, and then adding the ethanol, essence and phenoxyethanol premixed solution in the step (2);
(5) mixing, filtering, and taking out.
Example 2
TABLE 2
The combination of herbal extracts in table 2 is a combination of vitex rotundifolia fruit extract, gentian extract and polygonum multiflorum root extract, which were prepared from the flowchart shown in fig. 1.
The preparation method comprises the following steps:
(1) premixing p-hydroxyacetophenone and butanediol at the temperature of 20-30 ℃, heating to 80-85 ℃, and stirring until the p-hydroxyacetophenone and the butanediol are dissolved;
(2) premixing ethanol, essence and phenoxyethanol at 20-30 ℃, and stirring until the ethanol, the essence and the phenoxyethanol are dissolved;
(3) heating water to 60-70 ℃ at 20-30 ℃, adding the premixed solution of p-hydroxyacetophenone and butanediol in the step (1), uniformly stirring, adding hexamidine di (hydroxyethyl sulfonate) salt, and uniformly stirring until the hexamidine di (hydroxyethyl sulfonate) salt is uniformly dispersed;
(4) cooling the solution in the step (3) to below 45 ℃, and then adding the ethanol, essence and phenoxyethanol premixed solution in the step (2);
(5) adding an antipruritic agent at the temperature of 20-30 ℃, and stirring until the antipruritic agent is uniformly dispersed;
(6) mixing, filtering, and taking out.
Example 3
TABLE 3
The combination of herbal extracts in table 3 and the combination of herbal extracts in example 2 refer to the same.
The preparation method comprises the following steps:
(1) premixing p-hydroxyacetophenone and butanediol at the temperature of 20-30 ℃, heating to 80-85 ℃, and stirring until the p-hydroxyacetophenone and the butanediol are dissolved;
(2) premixing ethanol, essence and phenoxyethanol at 20-30 ℃, and stirring until the ethanol, the essence and the phenoxyethanol are dissolved;
(3) heating water to 60-70 ℃ at 20-30 ℃, adding the premixed solution of p-hydroxyacetophenone and butanediol in the step (1), uniformly stirring, adding hexamidine di (hydroxyethyl sulfonate) salt, and uniformly stirring until the hexamidine di (hydroxyethyl sulfonate) salt is uniformly dispersed;
(4) cooling the solution in the step (3) to below 45 ℃, and then adding the ethanol, essence and phenoxyethanol premixed solution in the step (2);
(5) adding an antipruritic agent at the temperature of 20-30 ℃, and stirring until the antipruritic agent is uniformly dispersed;
(6) mixing, filtering, and taking out.
Comparative example 1
TABLE 4
The vitex rotundifolia fruit extract, gentian extract and polygonum multiflorum root extract described in table 4 were prepared according to the flow charts shown in fig. 2-4, respectively.
The preparation method comprises the following steps:
(1) premixing p-hydroxyacetophenone and butanediol at the temperature of 20-30 ℃, heating to 80-85 ℃, and stirring until the p-hydroxyacetophenone and the butanediol are dissolved;
(2) premixing ethanol, essence and phenoxyethanol at 20-30 ℃, and stirring until the ethanol, the essence and the phenoxyethanol are dissolved;
(3) heating water to 60-70 ℃ at 20-30 ℃, adding the premixed solution of p-hydroxyacetophenone and butanediol in the step (1), uniformly stirring, adding hexamidine di (hydroxyethyl sulfonate) salt, and uniformly stirring until the hexamidine di (hydroxyethyl sulfonate) salt is uniformly dispersed;
(4) cooling the solution in the step (3) to below 45 ℃, and then adding the ethanol, essence and phenoxyethanol premixed solution in the step (2);
(5) adding an antipruritic agent at the temperature of 20-30 ℃, and stirring until the antipruritic agent is uniformly dispersed;
(6) mixing, filtering, and taking out.
Comparative example 2
TABLE 5
The vitex rotundifolia fruit extract, gentian extract and polygonum multiflorum root extract described in table 5 were prepared according to the flow charts shown in fig. 2-4, respectively.
The preparation method comprises the following steps:
(1) premixing p-hydroxyacetophenone and butanediol at the temperature of 20-30 ℃, heating to 80-85 ℃, and stirring until the p-hydroxyacetophenone and the butanediol are dissolved;
(2) premixing ethanol, essence and phenoxyethanol at 20-30 ℃, and stirring until the ethanol, the essence and the phenoxyethanol are dissolved;
(3) heating water to 60-70 ℃ at 20-30 ℃, adding the premixed solution of p-hydroxyacetophenone and butanediol in the step (1), uniformly stirring, adding hexamidine di (hydroxyethyl sulfonate) salt, and uniformly stirring until the hexamidine di (hydroxyethyl sulfonate) salt is uniformly dispersed;
(4) cooling the solution in the step (3) to below 45 ℃, and then adding the ethanol, essence and phenoxyethanol premixed solution in the step (2);
(5) adding an antipruritic agent at the temperature of 20-30 ℃, and stirring until the antipruritic agent is uniformly dispersed;
(6) mixing, filtering, and taking out.
Example 4
TABLE 6
The combination of herbal extracts in table 6 and the combination of herbal extracts in example 2 refer to the same.
The preparation method comprises the following steps:
(1) premixing p-hydroxyacetophenone and butanediol at the temperature of 20-30 ℃, heating to 80-85 ℃, and stirring until the p-hydroxyacetophenone and the butanediol are dissolved;
(2) premixing ethanol, essence, menthol and phenoxyethanol at 20-30 ℃, and stirring until the ethanol, the essence, the menthol and the phenoxyethanol are dissolved;
(3) heating water to 60-70 ℃ at 20-30 ℃, adding the premixed solution of p-hydroxyacetophenone and butanediol in the step (1), uniformly stirring, adding hexamidine di (hydroxyethyl sulfonate) salt, and uniformly stirring until the hexamidine di (hydroxyethyl sulfonate) salt is uniformly dispersed;
(4) cooling the solution in the step (3) to below 45 ℃, and then adding the ethanol, essence, menthol and phenoxyethanol premixed solution in the step (2);
(5) adding the traditional Chinese medicine extract composition, PCA zinc, xylitol-based glucoside and dehydrated xylitol and xylitol under the condition of 20-30 ℃, and stirring until the components are uniformly dispersed;
(6) mixing, filtering, and taking out.
Test example 1 stability test results
The room temperature conditions of formulations 1-22 were recorded and the overall homogeneous samples were tested for stability (-15 ℃, 4 ℃, 45 ℃) for 7 days and the stability results are reported in Table 7.
TABLE 7
By comparing formulations 1-4, the antidandruff agent in the formulation of the present invention is optionally hexamidine bis (isethionate) salt. Compared with other antidandruff agents, the composition added with hexamidine di (isethionic acid) salt is more soluble in water, so that the shampoo agent product can exert stronger antidandruff effect.
Test example 2 Malassezia bacteriostatic rate test result
Scalp essence samples prepared according to the formula 3, the formula 5, the formula 6, the formula 7 and the formula 8 are tested for the malassezia bacteriostasis rate according to the method in 7.3.3 of QB/T2738-2012 evaluation method for antibacterial and bacteriostatic effects of daily products to evaluate the optimal proportion of hexamidine-bis (isethionic acid) salt in scalp essence, and the results are shown in Table 8.
TABLE 8
By comparing the formula 3, the formula 5, the formula 6, the formula 7 and the formula 8, the anti-dandruff agent hexamidine di (isethionic acid) salt has the anti-dandruff effect within the range of 0.01-0.1%.
Test example 3 evaluation of antipruritic efficacy
Use of H in the invention2O2The evaluation of the efficacy of the antipruritic materials is studied as an irritant. When high concentration of H2O2When the skin care liquid is applied to the skin, strong stabbing pain and itching can be generated, and simultaneously, the TEWL value (percutaneous water loss rate) of the skin is increased, and erythema symptoms are generated. Applying different scalp essence samples on skin, if skin TEWL value is reduced, indicating that scalp essence can relieve H2O2The barrier damage and inflammatory reaction are caused, and the effect of relieving itching is achieved. Selecting 31 normal healthy subjects, wherein male 11, is about 29 years of age; female 20 people, average age about 28 years. The temperature is (20 +/-2) DEG C and the relative humidity is 30-60% during the test period. Determining the inner side of forearm of left and right hands as test region with area of 3cm × 3cm, marking 3 regions, and collecting 20 μ L30% H2O2The solution is applied to the marked area, and 3min later, a TM-300 probe is used for detecting the percutaneous water loss (TEWL) value. Then 20 μ L of scalp essence solution is smeared on H2O2And (5) detecting the change of the skin TEWL value in the injury position by applying a TM-300 probe within 30 min. Wherein the blank group is not coated with H2O2Solution, control group is smear H2O2The solution was not treated at all.
TABLE 9
Examples | TEML value |
Blank group | 13.25 |
Control group | 35.60 |
Formulation 9 | 12.60 |
Formulation 10 | 15.38 |
Formulation 11 | 20.73 |
Formulation 12 | 24.08 |
Formulation 13 | 34.76 |
Formulation 14 | 18.21 |
Formulation 15 | 31.29 |
Formulation 16 | 26.63 |
Formulation 17 | 30.90 |
Formulation 18 | 15.23 |
By comparing formulas 9-18, the antipruritic agent of the present invention is preferably the combination of herbal extracts (i.e., the combination of the extract of fructus viticis, the extract of radix gentianae, and the extract of radix polygoni multiflori). And the vitex rotundifolia fruit extract, the gentian extract and the polygonum multiflorum root extract have a synergistic effect after being combined. Compared with other antipruritic agents, the traditional Chinese medicine extract composition added in the formula can relieve scalp inflammatory reaction and exert the effects of resisting inflammation and relieving itching; and the compatibility of the system is best, and the product is not easy to separate out or layer.
Test example 4 selection of ratio of anti-dandruff agent to antipruritic agent
In order to determine the optimal proportion of the combination of the anti-dandruff agent hexamidine di (isethionic acid) salt and the traditional Chinese medicine extract (namely the combination of the vitex rotundifolia fruit extract, the gentian extract and the polygonum multiflorum root extract) in the scalp essence, the combination of the hexamidine di (isethionic acid) salt and the traditional Chinese medicine extract in different proportions is selected and applied to the scalp essence, as shown in formulas 19 to 22. The results of the Malassezia bacteriostasis test and the TEWL values for formulations 19-22 are shown in Table 10.
Watch 10
According to the malassezia bacteriostasis rate data and the TEWL value, the formulas 19-22 are found to have ideal performance in inhibiting the malassezia, recovering the skin barrier and relieving itching.
Test example 5 evaluation results of consumers
120 women with dandruff and head itching problems in 18-35 years old are selected as experimental objects, 30 women are randomly selected to be divided into four groups, and scalp essence is prepared according to formulas 19-22 to carry out dandruff removing and itching relieving tests. A tester firstly uses shampoo to clean scalp and hair, and after the scalp is dry, the scalp essence is uniformly sprayed on the scalp, and the scalp essence is slightly rubbed to promote absorption. The scalp essence of the invention is used by each person of the experimental group once every 2 days, and the experimental period is 28 days. Before the experiment begins, the testee firstly scores the scurf and the itching of the testee, 0-5 scores of the scurf (0 score has no scurf, 5 scores of the scurf are very serious), 0-4 scores of the itching of the testee (0 score has no sense, 4 scores of the scurf and the itching of the testee are very itchy and cannot be tolerated), and the testee scores the scurf and the itching of the testee according to the situation of the scurf and the itching of the testee after the use is finished. The results are detailed in Table 11.
W28 refers to the test subjects using scalp essence for 28 days.
W0 refers to the scalp before the tester applies the scalp essence.
TABLE 11
The experimental results are as follows: after the scalp essence is used by a tester for 28 days, the dandruff condition is improved, and the improvement degrees of the formulas 19 to 22 are 37.91%, 50.48%, 50.99% and 53.39% respectively. From the data, the anti-dandruff effect of the 4 formulations is formulation 22, formulation 21 to formulation 20, formulation 19, from which it is known that the anti-dandruff agent hexamidine di (isethionic acid) salt is uniform in the range of 0.005% to 0.01% in scalp treatment; the scalp itching degree can be improved, and the improvement degrees of the formulas 19 to 22 are respectively 38.80%, 47.58%, 42.51% and 21.49%. From the data, the anti-itching effect of the 4 formulas is that the formula 20 is greater than the formula 21 is greater than the formula 19 is greater than the formula 22, and according to the test results of the formulas 19 to 22, the anti-dandruff effect of the scalp essence can be maximally exerted when the content of the anti-dandruff agent hexamidine di (isethionic acid) salt in the formula is 0.01 percent and the combined content of the traditional Chinese medicine extracts is 2 percent.
At the same time of the consumer test, the scalp of the consumer with the self-rated dandruff of 2.5 or more was photographed by a VC 98 digital camera in follow-up, including W0 before the start of the test and W28 after 28 days, and the results are shown in FIGS. 5-8.
Wherein figure 5 is a scalp front to back comparison of formula 19 subjects; FIG. 6 is a comparison of formula 20 before and after the scalp of the subject; FIG. 7 is a comparison of formula 21 before and after the scalp of the subject; fig. 8 is a scalp front-to-back comparison of formula 22 subjects.
Claims (10)
1. A composition comprising hexamidine bis (isethionate) salt and a herbal extract; the Chinese medicinal extract comprises radix Gentianae extract.
2. The composition of claim 1, wherein the herbal extract further comprises one or both of a Vitex rotundifolia fruit extract and a Polygonum multiflorum root extract;
preferably, the composition further comprises a combination of a vitex rotundifolia fruit extract, a polygonum multiflorum root extract.
3. The composition of claim 1, comprising the following components in parts by weight: 0.001-0.1 parts of hexamidine di (isethionic acid) salt and 0.1-5 parts of traditional Chinese medicine extract;
preferably, the composition comprises the following components in parts by weight: 0.001-0.08 part of hexamidine di (isethionic acid) salt and 0.3-3 parts of traditional Chinese medicine extract;
more preferably, the composition comprises the following components in parts by weight: 0.001-0.05 parts of hexamidine di (isethionic acid) salt and 0.5-2 parts of traditional Chinese medicine extract.
4. The composition of claim 1, further comprising p-hydroxyacetophenone and phenoxyethanol;
preferably, the composition comprises the following components in parts by weight: 0.1-1 part of p-hydroxyacetophenone and 0.1-1 part of phenoxyethanol;
further preferably, the composition comprises the following components in parts by weight: 0.1-0.8 part of p-hydroxyacetophenone and 0.1-0.8 part of phenoxyethanol.
5. More preferably, the composition comprises the following components in parts by weight: 0.1-0.5 part of p-hydroxyacetophenone and 0.1-0.5 part of phenoxyethanol. The composition of claim 2, wherein the mass ratio of the vitex rotundifolia fruit extract, the gentian extract and the polygonum multiflorum root extract in the traditional Chinese medicine extract is (1-50): (1-50): (1-50);
preferably, in the composition, the mass ratio of the vitex rotundifolia fruit extract to the gentian extract to the polygonum multiflorum root extract is (1-20): (20-50): (10-40);
more preferably, in the composition, the mass ratio of the vitex rotundifolia fruit extract to the gentian extract to the polygonum multiflorum root extract is (1-10): (30-50): (20-40).
6. Use of a composition according to any one of claims 1 to 5 in cosmetics;
preferably, the cosmetic is scalp essence or shampoo
Or for scalp antipruritic use; or
Application in removing dandruff.
7. A cosmetic comprising the composition according to any one of claims 1 to 5; ethanol, butanediol and water;
preferably, the composition further comprises zinc PCA and xylitol-based glucoside & anhydroxylitol & xylitol;
further preferably, the cosmetic comprises the following components in parts by weight: 1-20 parts of ethanol, 1-5 parts of butanediol, 80-90 parts of water, 0.1-0.5 part of PCA zinc and 0.1-1 part of xylitol-based glucoside and dehydrated xylitol;
still further preferably, the cosmetic comprises the following components in parts by weight: 5-15 parts of ethanol, 2-5 parts of butanediol, 85-90 parts of water, 0.1-0.3 part of PCA zinc and 0.2-1 part of xylitol-based glucoside and dehydrated xylitol;
more preferably, the cosmetic comprises the following components in parts by weight: 10-15 parts of ethanol, 3-5 parts of butanediol, 88-90 parts of water, 0.1-0.2 part of PCA zinc and 0.2-0.7 part of xylitol-based glucoside and dehydrated xylitol.
8. The cosmetic of claim 7, comprising the following components in weight percent:
0.1 to 1 percent of p-hydroxyacetophenone;
hexamidine di (isethionic acid) salt 0.001% -0.1%;
0.1 to 1 percent of phenoxyethanol;
0.1 to 5 percent of traditional Chinese medicine extract;
xylitol-based glucoside & anhydroxylitoxylite & xylitol 0.1% -1%;
0.1 to 0.5 percent of PCA zinc;
1% -20% of ethanol;
1% -5% of butanediol;
water to 100 percent;
preferably, the cosmetic comprises the following components in percentage by weight:
0.1 to 0.8 percent of p-hydroxyacetophenone;
hexamidine di (isethionic acid) salt 0.001% -0.08%;
0.1 to 0.8 percent of phenoxyethanol;
0.3 to 3 percent of traditional Chinese medicine extract;
xylitol-based glucoside & anhydroxylitol & xylitol 0.2% -1%;
0.1 to 0.3 percent of PCA zinc;
5% -15% of ethanol;
2% -5% of butanediol;
water to 100 percent;
more preferably, the cosmetic comprises the following components in percentage by weight:
0.1 to 0.5 percent of p-hydroxyacetophenone;
hexamidine di (isethionate) salt 0.001% -0.05%;
0.1 to 0.5 percent of phenoxyethanol;
0.5 to 2 percent of traditional Chinese medicine extract;
xylitol-based glucoside & anhydroxylitoxylite & xylitol 0.2% -0.7%;
0.1% -0.2% of PCA zinc;
10% -15% of ethanol;
3% -5% of butanediol;
water to 100 percent.
9. The cosmetic of claim 8, wherein the cosmetic further comprises menthol and a fragrance;
preferably, the weight percentage of the menthol is 0.01-0.1%.
10. A process for preparing a cosmetic product according to any one of claims 7 to 9, comprising the steps of:
(1) premixing p-hydroxyacetophenone and butanediol at 0-30 ℃, heating to 80-85 ℃, and stirring until the mixture is dissolved;
(2) premixing ethanol, menthol, essence and phenoxyethanol at 0-30 ℃, and stirring until the ethanol, the menthol, the essence and the phenoxyethanol are dissolved;
(3) heating water to 60-70 ℃ at 0-30 ℃, adding the premixed solution of p-hydroxyacetophenone and butanediol in the step (1), uniformly stirring, adding hexamidine di (hydroxyethyl sulfonate) and stirring until the mixture is uniformly dispersed;
(4) cooling the solution in the step (3) to below 45 ℃, and then adding the ethanol, menthol, essence and phenoxyethanol premixed solution in the step (2);
(5) adding the traditional Chinese medicine extract, xylitol-based glucoside, dehydrated xylitol and PCA zinc into the solution obtained in the step (4), and stirring until the traditional Chinese medicine extract, the xylitol-based glucoside, the dehydrated xylitol and the xylitol are completely dissolved;
(6) mixing, filtering, and taking out.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911013093.0A CN110693776A (en) | 2019-10-23 | 2019-10-23 | Dandruff-removing and itching-relieving scalp essence and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911013093.0A CN110693776A (en) | 2019-10-23 | 2019-10-23 | Dandruff-removing and itching-relieving scalp essence and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110693776A true CN110693776A (en) | 2020-01-17 |
Family
ID=69201403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911013093.0A Pending CN110693776A (en) | 2019-10-23 | 2019-10-23 | Dandruff-removing and itching-relieving scalp essence and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110693776A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111096917A (en) * | 2020-01-19 | 2020-05-05 | 广州妮趣化妆品有限公司 | Long-acting anti-dandruff itching-relieving composition and application thereof |
CN111686049A (en) * | 2020-07-14 | 2020-09-22 | 孙开军 | Antibacterial and acarid-removing shampoo and preparation method thereof |
CN111821232A (en) * | 2020-06-24 | 2020-10-27 | 名臣健康用品股份有限公司 | Oil-controlling and itching-relieving composition for hair and application thereof |
CN111904882A (en) * | 2020-08-31 | 2020-11-10 | 广州市发觉化妆品贸易有限公司 | A composition with effects of controlling oil, removing dandruff, removing mite and preventing alopecia, and its preparation method |
CN113116737A (en) * | 2021-04-23 | 2021-07-16 | 广州妮趣化妆品有限公司 | Application of composition with alopecia preventing effect in scalp essence and preparation method thereof |
CN113842342A (en) * | 2021-09-14 | 2021-12-28 | 广州锦同生物科技有限公司 | Plant dandruff-removing and itching-relieving agent as well as preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105078778A (en) * | 2015-07-14 | 2015-11-25 | 拉芳家化股份有限公司 | Anti-dandruff shampoo capable of repairing scalp microecological system and application of anti-dandruff shampoo |
CN106344423A (en) * | 2016-11-02 | 2017-01-25 | 广州美尔生物科技有限公司 | Composition with dandruff removal and itch relieving effects and hair shampooing care product containing composition |
CN108403556A (en) * | 2018-04-29 | 2018-08-17 | 佛山云裳化妆品有限公司 | A kind of Haircare composition and application with anti-dandruff effect |
CN109864930A (en) * | 2018-12-29 | 2019-06-11 | 上海珈凯生物科技有限公司 | A kind of composition of plant extracts with inflammation-resisting itch-stopping and preparation method thereof, application |
-
2019
- 2019-10-23 CN CN201911013093.0A patent/CN110693776A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105078778A (en) * | 2015-07-14 | 2015-11-25 | 拉芳家化股份有限公司 | Anti-dandruff shampoo capable of repairing scalp microecological system and application of anti-dandruff shampoo |
CN106344423A (en) * | 2016-11-02 | 2017-01-25 | 广州美尔生物科技有限公司 | Composition with dandruff removal and itch relieving effects and hair shampooing care product containing composition |
CN108403556A (en) * | 2018-04-29 | 2018-08-17 | 佛山云裳化妆品有限公司 | A kind of Haircare composition and application with anti-dandruff effect |
CN109864930A (en) * | 2018-12-29 | 2019-06-11 | 上海珈凯生物科技有限公司 | A kind of composition of plant extracts with inflammation-resisting itch-stopping and preparation method thereof, application |
Non-Patent Citations (1)
Title |
---|
郭建维等: "新型祛屑止痒剂", 《日用化学品科学》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111096917A (en) * | 2020-01-19 | 2020-05-05 | 广州妮趣化妆品有限公司 | Long-acting anti-dandruff itching-relieving composition and application thereof |
CN111821232A (en) * | 2020-06-24 | 2020-10-27 | 名臣健康用品股份有限公司 | Oil-controlling and itching-relieving composition for hair and application thereof |
CN111686049A (en) * | 2020-07-14 | 2020-09-22 | 孙开军 | Antibacterial and acarid-removing shampoo and preparation method thereof |
CN111686049B (en) * | 2020-07-14 | 2021-03-23 | 孙开军 | Antibacterial and acarid-removing shampoo and preparation method thereof |
CN111904882A (en) * | 2020-08-31 | 2020-11-10 | 广州市发觉化妆品贸易有限公司 | A composition with effects of controlling oil, removing dandruff, removing mite and preventing alopecia, and its preparation method |
CN113116737A (en) * | 2021-04-23 | 2021-07-16 | 广州妮趣化妆品有限公司 | Application of composition with alopecia preventing effect in scalp essence and preparation method thereof |
CN113842342A (en) * | 2021-09-14 | 2021-12-28 | 广州锦同生物科技有限公司 | Plant dandruff-removing and itching-relieving agent as well as preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110693776A (en) | Dandruff-removing and itching-relieving scalp essence and preparation method thereof | |
JP4603192B2 (en) | Hair scalp composition | |
CN108969424B (en) | Mild anti-dandruff itching-relieving composition and preparation method and application thereof | |
CN110652481B (en) | Hyaluronic acid mild moisturizing facial cleanser and preparation method thereof | |
KR20060049895A (en) | Compositions containing anti-acne agents and the use thereof | |
CN111228153A (en) | Composition with synergistic acne removing effect, cosmetic composition and preparation method thereof | |
CN115919733A (en) | Cosmetic composition for removing acne and preparation method thereof | |
BR102017003313B1 (en) | ANTI-DANDRUFF COMPOSITION AND METHOD FOR THE PREVENTION, REDUCTION OR TREATMENT OF DANDRUFF | |
US20200030398A1 (en) | Skin care composition | |
CN116270638A (en) | Hair care compositions | |
CN111184644B (en) | Application of artemisinin as antiallergic component in cosmetics | |
CN111888275B (en) | Composition and preparation method and application thereof | |
JPH03112912A (en) | Cosmetic composition | |
CN113876646A (en) | Traditional Chinese medicine dandruff-removing and itching-relieving agent for scalp health conditioning | |
KR100560304B1 (en) | Hair Cosmetic Composition For Anti-Dandruff | |
KR0154210B1 (en) | Hair cosmetic composition | |
KR102571226B1 (en) | Composition for improving scalp condition comprising gluconolactone and climbazole as active ingredients | |
RU2722823C2 (en) | Cosmetic composition for treating and preventing acne on skin | |
CN114344190A (en) | Anti-dandruff nourishing composition and application thereof in shampoo | |
US20220323795A1 (en) | Combination of ciclopiroxolamine and piroctone olamine for combating dandruff | |
CN114306152A (en) | Oil control composition for hair and application thereof | |
JPH0352806A (en) | Hair-raising agent | |
CN116265008A (en) | Composition with anti-dandruff and oil control effects, and preparation method and application thereof | |
CN114681360A (en) | Scalp care composition and application thereof | |
CN112353713A (en) | Hair care and hair loss prevention composition and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200117 |